arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2004.03715econ.GNphysics.soc-phq-fin.EC
收藏

关键知识产权:COVID-19大流行的发现

Crisis-Critical Intellectual Property: Findings from the COVID-19 Pandemic

Frank Tietze, Pratheeba Vimalnath, Leonidas Aristodemou, Jenny Molloy

摘要:

在国家和国际创新体系中,大流行病需要跨部门的许多参与者采取大规模行动,调动资源,有效地开发和制造所需的大量危机关键产品(CC产品)。如今,这还包括从复杂的流行病学模型、人工智能到用于预防、诊断和治疗的开放数据平台的数字创新。在疫情期间的众多挑战中,创新和制造业的利益相关者发现自己参与了新的关系,并可能面临知识产权(IP)相关的挑战。本文从知识产权的角度看待2019冠状病毒病大流行,以确定与大流行相关的知识产权考虑因素和知识产权挑战。重点是与研究,开发和紧急提升生产能力相关的挑战,以满足突然出现的巨大需求。其目的是提供一个避开知识产权挑战的结构,以避免在抗击流行病方面出现延误。我们确定了4个关注知识产权挑战的利益相关者群体:(i)政府,(ii)拥有现有危机关键知识产权的组织,被描述为危机关键部门的现任者(CC部门),(iii)通常不生产CC产品的其他部门的制造公司突然涌入CC部门以支持CC产品的制造(新进入者),以及(iv)大流行期间形成的自愿基层倡议。本文讨论了与技术和产品的开发和制造有关的知识产权挑战,这些技术和产品用于(i)预防(传播),(ii)感染患者的诊断和(iii)治疗方法的开发。我们提供了一个初步的讨论,潜在的应对措施,以减少在流行病期间工业利益相关者之间的知识产权相关的风险。

英文摘要:

Within national and international innovation systems a pandemic calls for large-scale action by many actors across sectors, to mobilise resources, developing and manufacturing Crisis-Critical Products (CC-Products) efficiently and in the huge quantities needed. Nowadays, this also includes digital innovations from complex epidemiological models, AI, to open data platforms for prevention, diagnostic and treatment. Amongst the many challenges during a pandemic, innovation and manufacturing stakeholders find themselves engaged in new relationships, and are likely to face intellectual property (IP) related challenges. This paper adopts an IP perspective on the COVID-19 pandemic to identify pandemic related IP considerations and IP challenges. The focus is on challenges related to research, development and urgent upscaling of capacity to manufacture CC-Products in the huge volumes suddenly in demand. Its purpose is to provide a structure for steering clear of IP challenges to avoid delays in fighting a pandemic. We identify 4 stakeholder groups concerned with IP challenges: (i) governments, (ii) organisations owning existing Crisis-Critical IP, described as incumbents in Crisis-Critical Sectors (CC-Sectors), (iii) manufacturing firms from other sectors normally not producing CC-Products suddenly rushing into CC-Sectors to support the manufacturing of CC-Products (new entrants), and (iv) voluntary grassroot initiatives that are formed during a pandemic. This paper discusses IP challenges related to the development and manufacturing of technologies and products for (i) prevention (of spread), (ii) diagnosis of infected patients and (iii) the development of treatments. We offer an initial discussion of potential response measures to reduce IP associated risks among industrial stakeholders during a pandemic.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑